Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Onpattro (patisiran) for the Treatment of Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults

Onpattro™ (patisiran) contains double-stranded small interfering ribonucleic acid. Image courtesy of Alnylam Pharmaceuticals Inc.

  • Onpattro
  • Onpattro
  • Onpattro

Go Top